I'm LongbridgeAI, I can summarize articles.Ironwood Pharmaceuticals CFO Ronald Silver sold 127,890 Class A common shares on July 7, 2026, at a weighted average price of $4.52, totaling approximately $578,063.80. Following the transaction, Silver retained a holding of 313,680 shares. The disclosure was filed via EDGAR.
- Ironwood Pharmaceuticals PFO and PAO Ronald Silver sold 127,890 Class A common shares on July 7, 2026. * Shares were sold at a weighted average price of $4.52. * Silver held 313,680 shares following the transaction. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Ironwood Pharmaceuticals Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001193125-26-299749), on July 09, 2026, and is solely responsible for the information contained therein. © Copyright 2026 - Public Technologies (PUBT) Original Document: here